Single-dose extended-release epidural morphine for pain after hip arthroplasty

Gavin Martin, MD; Maximilian Hartmannsgruber, MD; Edward Riley, MD; Garen Manvelian, MD

doi:10.5055/jom.2006.0033

Authors

Gavin Martin, MD
Maximilian Hartmannsgruber, MD
Edward Riley, MD
Garen Manvelian, MD

DOI:

https://doi.org/10.5055/jom.2006.0033

Keywords:

single-dose extended-release epidural morphine, postoperative pain management, orthopedic surgery

Abstract

This randomized, double-blind study compared the safety and efficacy of a new single-dose extended-release epidural morphine (EREM) formulation for postoperative pain following hip arthroplasty. Patients were administered a single dose of EREM (10, 20, or 30 mg, n = 93) or a single epidural dose of placebo (n = 27) before surgery and general anesthesia. Following surgery, patients had access to fentanyl with the use of intravenous patient-controlled analgesia. Postoperative fentanyl use, time to first postoperative fentanyl use, pain intensity at rest and with activity, patient ratings of pain control, and adverse events were recorded. Compared with placebo-treated patients, single-dose EREM patients used less total supplemental fentanyl (p £ 0.049), had a longer time to first fentanyl use (p < 0.001), and were less likely to use any supplemental fentanyl (p £ 0.042). EREM-treated patients reported lower pain intensity for up to 48 hours postdose compared with placebo-treated patients. Single-dose EREM was effective for postoperative pain relief for up to 48 hours following hip arthroplasty, with a safety and tolerability profile consistent with that of other epidurally administered opioids.

Author Biographies

Gavin Martin, MD

Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.

Maximilian Hartmannsgruber, MD

Department of Anesthesiology, New York University School of Medicine, New York, New York.

Edward Riley, MD

Stanford University School of Medicine, Stanford, California.

Garen Manvelian, MD

SkyePharma Inc, San Diego, California.

References

Rodgers A, Walker N, Schug S, et al.: Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: Results from overview of randomised trials. BMJ. 2000; 321: 1493.

Sinatra RS, Torres J, Bustos AM: Pain management after major orthopaedic surgery: Current strategies and new concepts. J Am Acad Orthop Surg. 2002; 10: 117-129.

Morrison RS, Magaziner J, McLaughlin MA, et al.: The impact of post-operative pain on outcomes following hip fracture. Pain. 2003; 103: 303-311.

Wu CL, Anderson GF, Herbert R, et al.: Effect of postoperative epidural analgesia on morbidity and mortality after total hip replacement surgery in medicare patients. Reg Anesth Pain Med. 2003; 28: 271-278.

Practice guidelines for acute pain management in the perioperative setting: An updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2004; 100: 1573-1581.

McQuay HJ, Carroll D, Moore RA: Postoperative orthopaedic pain—the effect of opiate premedication and local anaesthetic blocks. Pain. 1988; 33: 291-295.

Hendolin H, Nuutinen L, Kokki H, et al.: Does morphine premedication influence the pain and consumption of postoperative analgesics after total knee arthroplasty? Acta Anaesthesiol Scand. 1996; 40: 81-85.

Yeager MP, Glass DD, Neff RK, et al.: Epidural anesthesia and anal gesia in high-risk surgical patients. Anesthesiology. 1987; 66: 729-736.

Singelyn FJ, Deyaert M, Joris D, et al.: Effects of intravenous patient-controlled analgesia with morphine, continuous epidural analgesia, and continuous three-in-one block on postoperative pain and knee rehabilitation after unilateral total knee arthroplasty. Anesth Analg. 1998; 87: 88-92.

McBeath DM, Shah J, Sebastian L, et al.: The effect of patient controlled analgesia and continuous epidural infusion on length of hospital stay after total knee or total hip replacement. CRNA. 1995; 6: 31-36.

de Leon-Casasola OA, Parker BM, Lema MJ, et al.: Epidural analgesia versus intravenous patient-controlled analgesia. Differences in the postoperative course of cancer patients. Reg Anesth. 1994; 19: 307-315.

Ionescu TI, Taverne RH, Houweling P, et al.: A study of epidural morphine and sufentanil anesthesia for abdominal aortic surgery. Acta Anaesthesiol Belg. 1989; 40: 65-77.

Sjostrom S, Hartvig P, Persson MP, et al.: Pharmacokinetics of epidural morphine and meperidine in humans. Anesthesiology. 1987; 67: 877-888.

Capdevila X, Barthelet Y, Biboulet P, et al.: Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology. 1999; 91: 8-15.

Geerts WH, Pineo GF, Heit JA, et al.: Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126: 338S-400S.

Horlocker TT, Wedel DJ, Benzon H, et al.: Regional anesthesia in the anticoagulated patient: Defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation).Reg Anesth Pain Med. 2003; 28: 172-197.

Howell SB: Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam technology. Cancer J. 2001; 7: 219-227.

Yaksh TL, Provencher JC, Rathbun ML, et al.: Safety assessment of encapsulated morphine delivered epidurally in a sustained-release multivesicular liposome preparation in dogs. Drug Deliv. 2000; 7: 27-36.

Kim T, Murdande S, Gruber A, et al.: Sustained-release morphine for epidural analgesia in rats. Anesthesiology. 1996; 85: 331-338.

Gambling D, Hughes T, Martin G, et al.: A comparison of Depodur, a novel, single-dose extended-release epidural morphine, with standard epidural morphine for pain relief after lower abdominal surgery. Anesth Analg. 2005; 100: 1065-1074.

Carvalho B, Riley E, Cohen SE, et al.: Single-dose, sustainedrelease epidural morphine in the management of postoperative pain after elective cesarean delivery: Results of a multicenter randomized controlled study. Anesth Analg. 2005; 100: 1150-1158.

Viscusi ER, Martin G, Hartrick CT, et al.: 48 hours of postoperative pain relief following total hip arthroplasty with a novel, extended-release epidural morphine formulation. Anesthesiology. 2005; 102: 1014-1022.

SAS Institute Inc: SAS OnlineDoc®. SAS Institute Inc. Web site. Available at v8doc.sas.com/sashtml/. Accessed October 28, 2004.

Wu CL, Naqibuddin M, Rowlingson AJ, et al.: The effect of pain on health-related quality of life in the immediate postoperative period. Anesth Analg. 2003; 97: 1078-1085, table of contents.

Sarvela J, Halonen P, Soikkeli A, et al.: A double-blinded, randomized comparison of intrathecal and epidural morphine for elective cesarean delivery. Anesth Analg. 2002; 95: 436-440.

White MJ, Berghausen EJ, Dumont SW, et al.: Side effects during continuous epidural infusion of morphine and fentanyl. Can J Anaesth. 1992; 39: 576-582.

Cashman JN, Dolin SJ: Respiratory and haemodynamic effects of acute postoperative pain management: Evidence from published data. Br J Anaesth. 2004; 93: 212-223.

DepoDur™ Prescribing Information. Chadds Ford: Endo Pharmaceuticals Inc., 2004.

Marret E, Kurdi O, Zufferey P, et al.: Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects: Meta-analysis of randomized controlled trials. Anesthesiology. 2005; 102: 1249-1260.

Salvati EA, Pellegrini VD Jr, Sharrock NE, et al.: Recent advances in venous thromboembolic prophylaxis during and after total hip replacement. J Bone Joint Surg Am. 2000; 82: 252-270.